The requirement for androgen in PCa progression has led to the development of androgen deprivation therapy (ADT) by orchiectomy or luteinizing hormone-releasing hormone (LHRH) agonists and LHRH antagonists 6. This evidence concerns the gene GNRH1 and posterior cortical atrophy.